Cover Image
市場調查報告書

過敏症:全球臨床實驗檢討

Hypersensitivity Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318340
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
過敏症:全球臨床實驗檢討 Hypersensitivity Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 80 Pages
簡介

本報告提供過敏症相關相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,各地區、Phase、階段的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,加上有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

  • 簡介
    • 過敏症
    • 本報告概要
  • 各地區的臨床實驗情形
    • 各國臨床實驗數量和平均實驗人數
      • 亞太地區主要5個國家的臨床實驗數量
      • 歐洲主要5個國家的臨床實驗數量
      • 北美主要國家的臨床實驗數量
      • 中東·非洲主要5個國家的臨床實驗數量
      • 中南美主要國家的臨床實驗數量
  • G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上過敏症所佔的比例
  • G7各國臨床實驗數量:Phase別
  • G7各國臨床實驗數量:各進展狀況
  • E7各國臨床實驗數量:免疫疾病治療藥臨床實驗上過敏症所佔的比例
  • E7各國臨床實驗數量:Phase別
  • E7各國臨床實驗數量:各進展狀況
  • Phase別臨床實驗數量
    • 進行中的臨床實驗:不同階段
  • 各進展狀況臨床實驗數量
  • 臨床實驗的目標的成就情形
  • 未完成的臨床實驗數量:過敏症的情況
  • 一定期間所採用的實驗對像
  • 贊助商類別的臨床實驗數量
  • 有潛力的贊助商
    • 過敏症的治療藥臨床實驗的主要參與企業
  • 有潛力的藥劑
  • 臨床實驗簡介
    • 主要企業臨床實驗概要
      • Allergy Therapeutics plc
      • GlaxoSmithKline plc
      • Merck & Co., Inc.
      • 小野藥品工業
      • Laboratorios LETI S.L.
      • United Pharmaceuticals SA
      • Sanofi
      • Procter & Gamble Srl
      • Noblewell, Inc
      • Allertein Therapeutics, LLC
    • 主要研究機關/政府臨床實驗概要
      • The National Institute of Allergy and Infectious Diseases
      • The University of North Carolina at Chapel Hill
      • Assistance Publique - Hopitaux de Paris
      • Maastricht University Medical Center
      • University Hospital Inselspital, Berne
      • Imperial College London
      • The Children's Hospital of Philadelphia
      • Isfahan University of Medical Sciences
      • Chinese University of Hong Kong
      • National Institute of Neurological Disorders and Stroke
  • 5個有代表性的臨床實驗簡介
  • 附錄

圖表一覽

目錄
Product Code: GDHC2389CTIDB

GlobalData's clinical trial report, "Hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Hypersensitivity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypersensitivity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypersensitivity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hypersensitivity
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hypersensitivity to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hypersensitivity to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hypersensitivity
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hypersensitivity Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Allergy Therapeutics plc
      • Clinical Trial Overview of Allergy Therapeutics plc
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Ono Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Ono Pharmaceutical Co., Ltd.
      • Laboratorios LETI S.L.
      • Clinical Trial Overview of Laboratorios LETI S.L.
      • United Pharmaceuticals SA
      • Clinical Trial Overview of United Pharmaceuticals SA
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Procter & Gamble Srl
      • Clinical Trial Overview of Procter & Gamble Srl
      • Noblewell, Inc
      • Clinical Trial Overview of Noblewell, Inc
      • Allertein Therapeutics, LLC
      • Clinical Trial Overview of Allertein Therapeutics, LLC
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • The University of North Carolina at Chapel Hill
      • Clinical Trial Overview of The University of North Carolina at Chapel Hill
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Maastricht University Medical Center
      • Clinical Trial Overview of Maastricht University Medical Center
      • University Hospital Inselspital, Berne
      • Clinical Trial Overview of University Hospital Inselspital, Berne
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • The Children's Hospital of Philadelphia
      • Clinical Trial Overview of The Children's Hospital of Philadelphia
      • Isfahan University of Medical Sciences
      • Clinical Trial Overview of Isfahan University of Medical Sciences
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hypersensitivity Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hypersensitivity to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hypersensitivity Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Hypersensitivity Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Hypersensitivity Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergy Therapeutics plc, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios LETI S.L., 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by United Pharmaceuticals SA, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Procter & Gamble Srl, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Noblewell, Inc, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allertein Therapeutics, LLC, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of North Carolina at Chapel Hill, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*
  • Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*

List of Figures

  • Hypersensitivity Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Hypersensitivity Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Proportion of Hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hypersensitivity to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hypersensitivity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top